ClinicalTrials.gov
ClinicalTrials.gov Menu

The PUMA Trial is a Trial of a Single ProHema Modulated-CB Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01627314
Recruitment Status : Terminated (Business decision)
First Posted : June 25, 2012
Last Update Posted : August 22, 2017
Sponsor:
Information provided by (Responsible Party):
Fate Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : February 2017
  Actual Study Completion Date : May 2017